Hasil Pencarian - Sam Salek

Perbaiki Hasil
  1. 1
    The development and validation of a generic instrument, QoDoS, for assessing the quality of decision making

    The development and validation of a generic instrument, QoDoS, for assessing the quality of decision making oleh Ronan Donelan, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2016-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices

    Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices oleh Hasumati Rahalkar, Hasumati Rahalkar, Alan Sheppard, Sam Salek, Sam Salek

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans

    Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans oleh Sam Salek, Sam Salek, Sarah Lussier Hoskyn, Jeffrey Roy Johns, Nicola Allen, Chander Sehgal

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward

    Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward oleh Tariro Sithole, Tariro Sithole, Gugu Mahlangu, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward

    Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward oleh Tariro Sithole, Tariro Sithole, Gugu Mahlangu, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Patients’ needs in hematology: whose perspectives?

    Patients’ needs in hematology: whose perspectives? oleh Sam Salek, Tatyana Ionova, Esther Oliva

    Diterbitkan 2013-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY

    PB2551: GAUCHER DISEASE CURRICULUM: INCORPORATING GAUCHER DISEASE IN THE FIELD OF HEMATOLOGY oleh Argiris Symeonidis, Colm Bradley, Sam Salek

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Patient-centered research and practice in the era of genomics: a novel approach

    Patient-centered research and practice in the era of genomics: a novel approach oleh Sam Salek, Esther Oliva, Tatyana Ionova

    Diterbitkan 2016-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?

    A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment? oleh Nicola Allen, Nicola Allen, Lawrence Liberti, Stuart R. Walker, Stuart R. Walker, Sam Salek, Sam Salek

    Diterbitkan 2017-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities

    Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities oleh Lorraine Danks, Boitumelo Semete-Makokotlela, Kennedy Otwombe, Yashmika Parag, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward

    Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward oleh Nancy Ngum, Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry

    Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry oleh Mercy Owusu-Asante, Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries

    Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries oleh Mercy Owusu-Asante, Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement

    Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement oleh Nancy Ngum, Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker, Stuart Walker, Sam Salek, Sam Salek

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access

    South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access oleh Andrea Keyter, Sam Salek, Sam Salek, Lorraine Danks, Portia Nkambule, Boitumelo Semete-Makokotlela, Stuart Walker, Stuart Walker, Stuart Walker

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency

    A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency oleh Andrea Keyter, Sam Salek, Shabir Banoo, Stuart Walker

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines

    A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines oleh Magdalena Bujar, Neil McAuslane, Stuart Walker, Sam Salek

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines

    Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines oleh Hasumati Rahalkar, Hasumati Rahalkar, Hacer Coskun Cetintas, Sam Salek

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Two Minimal Clinically Important Difference (2MCID): A New Twist on an Old Concept

    Two Minimal Clinically Important Difference (2MCID): A New Twist on an Old Concept oleh Faraz M. Ali, M. Sam Salek, Andrew Y. Finlay

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities

    Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities oleh Hasumati Rahalkar, Hasumati Rahalkar, Alan Sheppard, Gustavo Mendes Lima Santos, Chitralekha Dasgupta, Sonia Mayra Perez-Tapia, Carlos A. Lopez-Morales, Sam Salek, Sam Salek

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: